| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-15 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-15 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-13 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-13 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-13 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |